BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Finsterer J, Frank M. Prevalence of neoplasms in definite and probable mitochondrial disorders. Mitochondrion 2016;29:31-4. [DOI: 10.1016/j.mito.2016.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Jerves T, Blau N, Ferreira CR. Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias. Molecular Genetics and Metabolism 2022. [DOI: 10.1016/j.ymgme.2022.03.011] [Reference Citation Analysis]
2 Finsterer J, Zarrouk-Mahjoub S. Single nucleotide mtDNA polymorphisms may contribute to cancerogenesis in mitochondrial disorders. Environ Mol Mutagen 2019;60:463-4. [PMID: 29536588 DOI: 10.1002/em.22180] [Reference Citation Analysis]
3 Finsterer J. Re: "Clinical Phenotype and Genetic Features of a Pair of Chinese Twins with Kearns-Sayre Syndrome" by Guo et al.. DNA Cell Biol 2020;39:1907-8. [PMID: 32876487 DOI: 10.1089/dna.2020.5882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Finsterer J, Scorza FA. Renal manifestations of primary mitochondrial disorders. Biomed Rep 2017;6:487-94. [PMID: 28515908 DOI: 10.3892/br.2017.892] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
5 Sondheimer N, Kaufman B, Picard M. Reply. Environ Mol Mutagen 2019;60:465. [PMID: 29536566 DOI: 10.1002/em.22181] [Reference Citation Analysis]
6 Finsterer J. Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially? Clin Pediatr Endocrinol 2018;27:107-8. [PMID: 29662271 DOI: 10.1297/cpe.27.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Finsterer J, Zarrouk-Mahjoub S. Letter to the Editor: Endocrine Compromise in Mitochondrial Disorders. J Endocr Soc 2018;2:570-1. [PMID: 29942921 DOI: 10.1210/js.2018-00093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
8 Finsterer J. Tongue Root Cyst as a Manifestation of the Variant m.3243A>G. Cureus 2021;13:e19060. [PMID: 34853765 DOI: 10.7759/cureus.19060] [Reference Citation Analysis]
9 Gaboon NEA, Banaganapalli B, Nasser K, Razeeth M, Alsaedi MS, Rashidi OM, Abdelwehab LS, Alahmadi TS, Safdar OY, Shaik J, Choudhry HMZ, Al-Numan HH, Khan MI, Al-Aama JY, Elango R, Shaik NA. Exome sequencing and metabolomic analysis of a chronic kidney disease and hearing loss patient family revealed RMND1 mutation induced sphingolipid metabolism defects. Saudi J Biol Sci 2020;27:324-34. [PMID: 31889854 DOI: 10.1016/j.sjbs.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
10 Leone G, Abla H, Gasparre G, Porcelli AM, Iommarini L. The Oncojanus Paradigm of Respiratory Complex I. Genes (Basel) 2018;9:E243. [PMID: 29735924 DOI: 10.3390/genes9050243] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Galvan DL, Mise K, Danesh FR. Mitochondrial Regulation of Diabetic Kidney Disease. Front Med (Lausanne) 2021;8:745279. [PMID: 34646847 DOI: 10.3389/fmed.2021.745279] [Reference Citation Analysis]
12 Morales-López RA, Sánchez-Ortiz R. Robotic radical prostatectomy in a patient with prostate cancer and MERRF syndrome, a rare mitochondrial disorder affecting muscle fibers. Urol Case Rep 2019;22:21-2. [PMID: 30364532 DOI: 10.1016/j.eucr.2018.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]